^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Lung Non-Small Cell Squamous Cancer |
| Drug: | Avastin (bevacizumab) (VEGF-A inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Published date:
09/15/2020
Excerpt:
Bevacizumab is not recommended for patients with squamous cell NSCLC.
